Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04503759 · ClinicalTrials.gov registry record
Artoss Foot and Ankle Surgery Registry
A clinical trial, sponsored by Artoss.
- Completed
- Registry status
- 200
- Enrollment target
NCT04503759 is a clinical trial that has completed, run by Artoss. The registered enrollment target is 200 participants.
The verdict
NCT04503759 has completed, sponsored by Artoss.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
This prospective registry was designed as an observational study to ascertain how commercially available NanoBone products are being used by surgeons performing foot and ankle surgery which involves bone grafting, as well as determining relevant patient outcomes.
Interventions
- OTHER NanoBone Bone Graft Substitute
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2024-05-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04503759
The ClinicalTrials.gov registry entry for NCT04503759 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Artoss, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NanoBone Bone Graft Substitute is the first listed.
NCT04503759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04503759 about?
NCT04503759 is a clinical study titled "Artoss Foot and Ankle Surgery Registry". This prospective registry was designed as an observational study to ascertain how commercially available NanoBone products are being used by surgeons performing foot and ankle surgery which involves bone grafting, as well as determining relevant patient outcomes.
What is the current status of trial NCT04503759?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2020-08-01. Estimated completion is 2024-05-10.
What interventions are being tested in trial NCT04503759?
The interventions under investigation include: NanoBone Bone Graft Substitute (OTHER).
Who is sponsoring clinical trial NCT04503759?
This trial is sponsored by Artoss, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.